Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Herborium Group, Inc. Announces No Disruptions From Hurricane Sandy



     Herborium Group, Inc. Announces No Disruptions From Hurricane Sandy

Company Will Issue Special News Release on the Progress of the Lasting Energy®
and Other Developments the Week of November 12th

PR Newswire

FORT LEE, N.J., Nov. 5, 2012

FORT LEE, N.J., Nov. 5, 2012 /PRNewswire/ -- Herborium Group, Inc., (OTC Pink:
HBRM) www.herborium.com, a Botanical Therapeutics® Company is happy to inform
investors that the company operations have not been disrupted by hurricane
Sandy. At the same time management thanks all of those who have expressed
their concerns for the well being of our people and the company.

"Optimized business model and pure luck had kept Herborium out of the major
impact of Sandy," stated Dr. Agnes P. Olszewski, Herborium's CEO and
Chairwoman.

"We are moving forward with preparations to launch our unique all herbal
energy formula Lasting Energy®.  This launch is especially important in light
of recent serious problems and ongoing investigation of caffeine, sugar and
Vit. B-Complex based energy products," Added Dr. Olszewski.

"We are also continuing our aggressive marketing of AcnEase®, proprietary all
herbal acne treatment already present on the markets of North America, Europe,
Australia and Asia.

"We will update investors on latest developments related to advancement of
Lasting Energy® and AcnEase® the week of November 12^th ," Concluded Dr.
Olszewski. 

Once again thank you to all who have been concern about us, and our hearts go
out to victims of Sandy.

About Herborium Group, Inc.

Herborium Group, Inc., a Botanical Therapeutics® company, focuses on
developing, licensing, and marketing proprietary, botanical based medicinal
products to consumers and healthcare professionals.  The Company uses clinical
validation to establish and maintain a differential advantage.  The company
sells its products in the US and Europe. For more information on the company
and its products, please visit www.herborium.com,  www.acnease.com and
www.herboriumsh.com.

One of our most important responsibilities is to communicate with shareholders
in an open and direct manner. Comments are based on current management
expectations, and are considered "forward-looking statements," generally
preceded by words such as "plans," "expects," "believes," "anticipates," or
"intends." We cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or alter
forward-looking statements as the result of new information or future events.
The Company urges investors to review the risks and uncertainties contained
within its filings with the OTC Markets and/or Securities and Exchange
Commission.

For more information please inquire: Investorsrelations@herborium.com

SOURCE Herborium Group, Inc.

Website: http://www.herborium.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement